VEGFA and retinopathy of prematurity: Eligible studies included preterm infants born 37 weeks of postmenstrual age or younger with stage 4 or 5 ROP who received scleral buckling surgery as a primary surgical intervention regardless of previous additional treatments, such as cryotherapy, laser photocoagulation or anti-VEGF injections.